AAAAAA

   
Results: 1-13 |
Results: 13
A SUBUNIT VACCINE CONSISTING OF GP130 OLIGOMERS BUT NOT OF GP130 MONOMERS PROTECTS RHESUS MACAQUES AGAINST PRODUCTIVE INFECTION WITH SIVMAC32H
Authors: PETRY H STAHLHENNIG C DITTMER U JONES D FARRAR G WACHTER H FUCHS D NISSLEIN T JURKIEWICZ E HUNSMANN G LUKE W
Citation: H. Petry et al., A SUBUNIT VACCINE CONSISTING OF GP130 OLIGOMERS BUT NOT OF GP130 MONOMERS PROTECTS RHESUS MACAQUES AGAINST PRODUCTIVE INFECTION WITH SIVMAC32H, AIDS, 12(3), 1998, pp. 329-330
SILENT INFECTION OF MACAQUES INOCULATED WITH LOW-DOSE SIVMAC(251 SPL)/
Authors: PETRY H DITTMER U STAHLHENNIG C JURKIEWICZ E HUNSMANN G LUKE W
Citation: H. Petry et al., SILENT INFECTION OF MACAQUES INOCULATED WITH LOW-DOSE SIVMAC(251 SPL)/, AIDS research and human retroviruses, 13(16), 1997, pp. 1355-1356
IDENTIFICATION OF THE V1 REGION AS A LINEAR NEUTRALIZING EPITOPE OF THE SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC ENVELOPE GLYCOPROTEIN
Authors: JURKIEWICZ E HUNSMANN G SCHAFFNER J NISSLEIN T LUKE W PETRY H
Citation: E. Jurkiewicz et al., IDENTIFICATION OF THE V1 REGION AS A LINEAR NEUTRALIZING EPITOPE OF THE SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC ENVELOPE GLYCOPROTEIN, Journal of virology, 71(12), 1997, pp. 9475-9481
ATTENUATED SIV IMPARTS IMMUNITY TO CHALLENGE WITH PATHOGENIC SPLEEN-DERIVED SIV BUT CANNOT PREVENT REPAIR OF THE NEF DELETION
Authors: STAHLHENNIG C DITTMER U NISSLEIN T PEKRUN K PETRY H JURKIEWICZ E FUCHS D WACHTER H RUD EW HUNSMANN G
Citation: C. Stahlhennig et al., ATTENUATED SIV IMPARTS IMMUNITY TO CHALLENGE WITH PATHOGENIC SPLEEN-DERIVED SIV BUT CANNOT PREVENT REPAIR OF THE NEF DELETION, Immunology letters, 51(1-2), 1996, pp. 129-135
SIMIAN IMMUNODEFICIENCY VIRUS (SIV) GP130 OLIGOMERS PROTECT RHESUS MACAQUES (MACACA-MULATTA) AGAINST THE INFECTION WITH SIVMAC32H GROWN ON T-CELLS OR DERIVED EX-VIVO
Authors: LUKE W COULIBALY C DITTMER U VOSS G OESTERLE R MAKOSCHEY B SAUERMANN U JURKIEWICZ E STAHLHENNIG C PETRY H HUNSMANN G
Citation: W. Luke et al., SIMIAN IMMUNODEFICIENCY VIRUS (SIV) GP130 OLIGOMERS PROTECT RHESUS MACAQUES (MACACA-MULATTA) AGAINST THE INFECTION WITH SIVMAC32H GROWN ON T-CELLS OR DERIVED EX-VIVO, Virology, 216(2), 1996, pp. 444-450
RAPID DEVELOPMENT OF VACCINE PROTECTION IN MACAQUES BY LIVE-ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS
Authors: STAHLHENNIG C DITTMER U NISSLEIN T PETRY H JURKIEWICZ E FUCHS D WACHTER H MATZRENSING K KUHN EM KAUP FJ RUD EW HUNSMANN G
Citation: C. Stahlhennig et al., RAPID DEVELOPMENT OF VACCINE PROTECTION IN MACAQUES BY LIVE-ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS, Journal of General Virology, 77, 1996, pp. 2969-2981
HIV-1 CROSS-NEUTRALIZING ANTIBODIES IN GERMAN HIV-1-INFECTED PATIENTSDO NOT CORRELATE WITH AN ANTIBODY-BINDING PATTERN AGAINST DIFFERENT HIV-1 ISOLATES
Authors: JURKIEWICZ E PETRY H SUTOR GC LANG S SCHEDEL I HUNSMANN G
Citation: E. Jurkiewicz et al., HIV-1 CROSS-NEUTRALIZING ANTIBODIES IN GERMAN HIV-1-INFECTED PATIENTSDO NOT CORRELATE WITH AN ANTIBODY-BINDING PATTERN AGAINST DIFFERENT HIV-1 ISOLATES, AIDS, 9(1), 1995, pp. 91-93
INACTIVATION OF SIMIAN IMMUNODEFICIENCY VIRUS BY HYDROSTATIC-PRESSURE
Authors: JURKIEWICZ E BILLASBOAS M SILVA JL WEBER G HUNSMANN G CLEGG RM
Citation: E. Jurkiewicz et al., INACTIVATION OF SIMIAN IMMUNODEFICIENCY VIRUS BY HYDROSTATIC-PRESSURE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(15), 1995, pp. 6935-6937
REACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 IN MACAQUES AFTERSIMIAN IMMUNODEFICIENCY VIRUS SIVMAC SUPERINFECTION
Authors: PETRY H DITTMER U STAHLHENNIG C COULIBALY C MAKOSCHEY B FUCHS D WACHTER H TOLLE T MORYSWORTMANN C KAUP FJ JURKIEWICZ E LUKE W HUNSMANN G
Citation: H. Petry et al., REACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 IN MACAQUES AFTERSIMIAN IMMUNODEFICIENCY VIRUS SIVMAC SUPERINFECTION, Journal of virology, 69(3), 1995, pp. 1564-1574
IMMUNIZATION WITH VIRION-DERIVED GLYCOPROTEIN-130 FROM HIV-2 OR SIV PROTECTS MACAQUES AGAINST CHALLENGE VIRUS GROWN IN HUMAN OR SIMIAN CELLS OR PREPARED EX-VIVO
Authors: STAHLHENNIG C COULIBALY C PETRY H VOSS G DITTMER U BODEMER W MAKOSCHEY B JURKIEWICZ E LUKE W HUNSMANN G
Citation: C. Stahlhennig et al., IMMUNIZATION WITH VIRION-DERIVED GLYCOPROTEIN-130 FROM HIV-2 OR SIV PROTECTS MACAQUES AGAINST CHALLENGE VIRUS GROWN IN HUMAN OR SIMIAN CELLS OR PREPARED EX-VIVO, AIDS research and human retroviruses, 10, 1994, pp. 190000027-190000032
SECONDARY METABOLITES BY CHEMICAL-SCREENING .23. WARATERPOLS, NEW PENICILLIUM METABOLITES AND THEIR DERIVATIVES
Authors: HENNE P THIERICKE R GRABLEY S HUTTER K WINK J JURKIEWICZ E ZEECK A
Citation: P. Henne et al., SECONDARY METABOLITES BY CHEMICAL-SCREENING .23. WARATERPOLS, NEW PENICILLIUM METABOLITES AND THEIR DERIVATIVES, Liebigs Annalen der Chemie, (5), 1993, pp. 565-571
CHEMICAL MODIFICATIONS OF AMINONAPHTHALENESULFONIC ACID-DERIVATIVES INCREASE EFFECTIVITY AND SPECIFICITY OF REVERSE-TRANSCRIPTASE INHIBITION AND CHANGE MODE OF ACTION REVERSE-TRANSCRIPTASE AND DNA-POLYMERASE-ALPHA INHIBITION
Authors: OESTERLE R JURKIEWICZ E LUKE W NICKEL P HUNSMANN G JENTSCH KD
Citation: R. Oesterle et al., CHEMICAL MODIFICATIONS OF AMINONAPHTHALENESULFONIC ACID-DERIVATIVES INCREASE EFFECTIVITY AND SPECIFICITY OF REVERSE-TRANSCRIPTASE INHIBITION AND CHANGE MODE OF ACTION REVERSE-TRANSCRIPTASE AND DNA-POLYMERASE-ALPHA INHIBITION, Antiviral research, 22(2-3), 1993, pp. 107-119
THIANGAZOLE, A NEW THIAZOLINE ANTIBIOTIC FROM POLYANGIUM SP (MYXOBACTERIA) - PRODUCTION, ANTIMICROBIAL ACTIVITY AND MECHANISM OF ACTION
Authors: KUNZE B JANSEN R PRIDZUN L JURKIEWICZ E HUNSMANN G HOFLE G REICHENBACH H
Citation: B. Kunze et al., THIANGAZOLE, A NEW THIAZOLINE ANTIBIOTIC FROM POLYANGIUM SP (MYXOBACTERIA) - PRODUCTION, ANTIMICROBIAL ACTIVITY AND MECHANISM OF ACTION, Journal of antibiotics, 46(11), 1993, pp. 1752-1755
Risultati: 1-13 |